Elon Musk took the stage for Tesla's 2023 Investor Day in Austin, Texas and unveiled what he called the company's Master Plan 3, which emphasizes "sustainable energy for all of Earth."
“There is a clear path to a sustainable-energy Earth," he said. "It doesn’t require destroying natural habitats. It doesn’t require us to be austere and stop using electricity and be in the cold or anything.”
Musk and Senior Vice President of Powertrain and Energy Engineering at Tesla Drew Baglino riffed about "re-powering the grid with renewable fuels" and expanded battery production.
The executives also reiterated the company's goal to produce 20 million electric vehicles per year by 2030 — a significant jump from the 1.31 million delivered in 2022.
Despite Musk's ambitious claims about the future of energy, investors were concerned over the lack of detail in the plan, prompting Tesla's stock to fall 5 percent in extended trading.
Blame geography for the U.S. getting hit by stronger, costlier, more varied and frequent extreme weather than anywhere on the planet, several experts said. But that's only part of it.
Residents across a wide swath of the U.S. raced Sunday to assess the destruction from fierce storms that spawned possibly dozens of tornadoes from the South and the Midwest into the Northeast.
The U.S. Food and Drug Administration has approved selling overdose antidote naloxone over-the-counter, marking the first time a opioid treatment drug will be available without a prescription.
Millions of Americans could lose access to Medicaid on April 1, and Joe Dunn, senior vice president of public policy at the National Association of Community Health Centers, joined Cheddar News' anchor Shannon LaNier to discuss what this means for public health.
One third of Americans don't have access to primary care providers in their communities, according to a study from the National Association of Community Health Centers published last month.
Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report.
